S. Dadwal

发表

Voriconazole Serum Concentrations in Obese and Overweight Immunocompromised Patients: A Retrospective Review

J. Ito, Sanjeet S. Dadwal, J. Kriengkauykiat, 2013, Pharmacotherapy.

Persistent Value of the Stethoscope in the Age of COVID-19

R. Gaynes, A. Maisel, F. Torriani, 2020, The American Journal of Medicine.

Cryptococcal Tongue Lesion in a Stem Cell Transplant Patient: First Reported Case

E. Maghami, S. Dadwal, David R. Reinstadler, 2012, Case reports in otolaryngology.

Infectious Disease Complications in Patients with Cancer.

S. Seo, Sanjeet S. Dadwal, S. Dadwal, 2021, Critical care clinics.

Dual roles of a novel oncolytic viral vector-based SARS-CoV-2 vaccine: preventing COVID-19 and treating tumor progression

M. Caligiuri, K. Yu, P. Keim, 2021, bioRxiv.

Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.

B. Williams, J. Zaia, A. Krieg, 2012, The Journal of infectious diseases.

Outcome of allogeneic hematopoietic cell transplantation after venetoclax and hypomethylating agent therapy for acute myeloid leukemia.

G. Marcucci, I. Aldoss, S. Forman, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recent advances in the molecular diagnosis of mucormycosis

D. Kontoyiannis, Sanjeet S. Dadwal, S. Dadwal, 2018, Expert review of molecular diagnostics.

Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)

G. Papanicolaou, S. Seo, M. Kamboj, 2022, Transplantation and Cellular Therapy.

Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants

Anna M. Acosta, P. Frankel, J. Zaia, 2022, iScience.

DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study

Cameron R. Wolfe, M. Boeckh, F. Marty, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity

I. Aldoss, J. Zaia, S. Forman, 2022, Blood Advances.

Epidemiology of Central Nervous System Fungal Infections

Sanjeet S. Dadwal, S. Dadwal, 2019, Fungal Infections of the Central Nervous System.

Infectious complications of immune checkpoint inhibitors in solid organ malignancies

R. Salgia, S. Pal, Sanjeet S. Dadwal, 2021, Cancer medicine.

American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients.

T. Hohl, M. Boeckh, D. Kontoyiannis, 2021, Transplantation and cellular therapy.

Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA‐Ven) or liposomal daunorubicin‐cytarabine (CPX‐351)

G. Marcucci, I. Aldoss, S. Forman, 2021, American journal of hematology.

Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents.

G. Marcucci, I. Aldoss, S. Forman, 2019, Blood advances.

The COVID‐19 infection control response at a large stand‐alone comprehensive cancer center in Los Angeles County

B. Tegtmeier, S. Dadwal, A. Flood, 2022, Cancer reports.

Infectious Disease Complications in Cancer Patients

S. Seo, Catherine Liu, S. Dadwal, 2021 .

Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease.

K. Huelsman, S. Forman, R. Spielberger, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Skin/nail infections with the addition of pertuzumab to trastuzumab-based chemotherapy

M. D'Apuzzo, J. Mortimer, Yuan Yuan, 2014, Breast Cancer Research and Treatment.

Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipients

Jerry Cheng, Weili Sun, S. Armenian, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Long term outcomes of patients with Acute Myeloid Leukemia treated with myeloablative FTBI based conditioning with Tacrolimus and sirolimus based GVHD prophylaxis regimen: 6 year follow up from Single Center.

G. Marcucci, I. Aldoss, S. Forman, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Approaches to the early treatment of invasive fungal infection

J. Ito, H. Lazarus, J. Kriengkauykiat, 2010, Leukemia & lymphoma.

Herpes Virus Infections Other than Cytomegalovirus in the Recipients of Hematopoietic Stem Cell Transplantation.

Sanjeet S. Dadwal, S. Dadwal, 2019, Infectious disease clinics of North America.

A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients

A. Limaye, M. Boeckh, G. Rahav, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chronic Leptomeningitis and Spinal Intradural Mass Secondary to Alternaria Infection in a Patient with Ventriculoperitoneal Shunt

R. Jandial, B. Tegtmeier, S. Dadwal, 2016, Case reports in infectious diseases.

Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study.

P. Hari, K. Peggs, Deepali Kumar, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Can a Simple Stool Swab Predict Bacteremia in High-Risk Hematopoietic Cell Transplant Recipients?

S. Pergam, S. Dadwal, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology

G. Papanicolaou, M. Kamboj, J. Wingard, 2022, Transplantation and Cellular Therapy.

A New Normal for The Clinician's Third Hand: Stethoscope Hygiene and Infection Prevention.

F. Torriani, W. Peacock, R. Chemaly, 2022, American journal of infection control.

Use of high-dose mesna and hyperhydration leads to lower incidence of hemorrhagic cystitis after posttransplant cyclophosphamide-based allogeneic transplantation

G. Marcucci, I. Aldoss, S. Forman, 2021, Bone Marrow Transplantation.

Osteoarticular Mycoses

B. Moriyama, D. Kontoyiannis, B. Rammaert, 2022, Clinical microbiology reviews.

Successful allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia in a patient with hepatic echinococcal cyst managed by delayed hepatectomy

S. Dadwal, J. Kim, P. Soriano, 2011, Transplant infectious disease : an official journal of the Transplantation Society.

Epidemiology and treatment approaches in management of invasive fungal infections

J. Ito, J. Kriengkauykiat, S. Dadwal, 2011, Clinical epidemiology.

Late‐occurring infections in a contemporary cohort of hematopoietic cell transplantation survivors

S. Armenian, Sanjeet S. Dadwal, F. L. Wong, 2020, Cancer medicine.

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic‐Cell Transplantation

Michael Boeckh, Yoshinobu Kanda, Hermann Einsele, 2017, The New England journal of medicine.

Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation

P. Frankel, J. Ito, S. Forman, 2015, European journal of haematology.

Draft Genome Sequence of a Clinical Isolate of Fusarium fujikuroi Isolated from a Male Patient with Acute Myeloid Leukemia

K. Venkateswaran, C. Urbaniak, K. Bagramyan, 2018, Genome Announcements.

Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients

G. Papanicolaou, M. Kamboj, M. Boeckh, 2020, Biology of Blood and Marrow Transplantation.

Breakthrough Invasive Fungal Infections in Patients with Hematologic Malignancy (HM) and Hematopoietic Cell Transplantation (HCT) Receiving Isavuconazole for Empiric or Directed Antifungal Therapy

J. Ito, J. Kriengkauykiat, B. Tegtmeier, 2016 .

Effect of isavuconazole on tacrolimus and sirolimus serum concentrations in allogeneic hematopoietic stem cell transplant patients: A drug‐drug interaction study

D. Pon, Sanjeet S. Dadwal, R. Nakamura, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients

G. Marcucci, S. Forman, R. Nakamura, 2021, Transplantation and Cellular Therapy.

A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.

G. Papanicolaou, K. Sullivan, T. Shea, 2014, Blood.

Safety of Isavuconazonium Sulfate in Pediatrics Patients With Hematologic Malignancies and Hematopoietic Cell Transplantation With Invasive Fungal Infections: A Real World Experience

J. Zaia, Weili Sun, Sanjeet S. Dadwal, 2020, Journal of pediatric hematology/oncology.

Letermovir and maribavir for pan‐resistant cytomegalovirus infection in a patient with haematologic malignancy: Consideration for combination therapy

J. Zain, B. Tegtmeier, S. Dadwal, 2022, Journal of clinical pharmacy and therapeutics.

SARS-CoV-2 Specific Monoclonal Antibody for the Treatment of Mild-to-Moderate COVID-19 in Cancer Patients: A Single-center Experience

P. Frankel, R. Taplitz, D. Nanayakkara, 2021, Journal of Infectious Diseases.

A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection

J. Zaia, D. Diamond, Sanjeet S. Dadwal, 2018, Expert review of vaccines.

Frequently Asked Questions about Mpox (Formerly Monkeypox Disease) for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Recipients from the American Society for Transplantation and Cellular Therapy

G. Papanicolaou, S. Pergam, E. Ford, 2023, Transplantation and cellular therapy.

Preventing Measles among Immunosuppressed Cancer and Hematopoietic Cell Transplant Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy.

M. Kamboj, J. Englund, S. Pergam, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Variation in Clinical Practice and Attitudes on Antibacterial Management of Fever and Neutropenia in Patients With Hematologic Malignancy: A Survey of Cancer Centers Across the United States

S. Seo, J. Barreto, E. Krantz, 2022, Open forum infectious diseases.

MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.

I. Aldoss, J. Zaia, J. Longmate, 2017, Blood.

Impact of Letermovir Use for Cytomegalovirus Prophylaxis on Re-Hospitalization Following Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of a Phase III Randomized Clinical Trial

Valerie Teal, S. Mt-Isa, S. Dadwal, 2021, PharmacoEconomics - Open.

Cost analysis of ganciclovir and foscarnet in recipients of allogeneic hematopoietic cell transplant with cytomegalovirus viremia

J. Zaia, J. Ito, J. Kriengkauykiat, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Update on prevention of cytomegalovirus in hematopoietic cell transplantation

S. Dadwal, 2019, Current opinion in infectious diseases.

Antimicrobial Stewardship in Cancer Patients: The Time is Now.

S. Seo, S. Pergam, L. Abbo, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

A. Nademanee, G. Marcucci, S. Forman, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States

G. Papanicolaou, R. Giller, A. Chandak, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study

G. Marcucci, I. Aldoss, S. Forman, 2023, Frontiers in Immunology.

ASH-ASTCT: SARS-CoV-2 Vaccines in Immunocompromised Patients FAQs (V3 Posted 6/14/2021)

Alpana, G. Papanicolaou, T. Hohl, 2021 .

Iron Overload is Associated with Delayed Engraftment and Increased Non-Relapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell Transplantation.

A. Nademanee, G. Marcucci, I. Aldoss, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection

M. Caligiuri, S. Whelan, B. Barker, 2023, Nature Communications.

Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses

Zane W. Fink, M. Caligiuri, M. Chee, 2020, Cell Reports Medicine.

A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract

M. Boeckh, R. Jordan, P. Ljungman, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation

S. Forman, Heeyoung Kim, S. Armenian, 2019, Bone Marrow Transplantation.

The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study

G. Marcucci, S. Forman, R. Nakamura, 2023, Stem cell research & therapeutics.

Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial

A. Sette, P. Frankel, J. Zaia, 2022, The Lancet Microbe.